Literature DB >> 10823655

Analysis of neutrophil proteins of patients with Behçet's disease by two-dimensional gel electrophoresis.

S Yamashita1, A Suzuki, T Yanagita, S Hirohata, M Kamada, S Toyoshima.   

Abstract

Protein changes in the neutrophils of patients with Behçet's disease were analyzed by high resolution two-dimensional gel electrophoresis to investigate the pathological features of Behçet's disease. Two clear protein spots were found to be differently expressed between healthy volunteers and patients with Behçet's disease. One was a 53 kDa protein with pI 5.2 that was detected in healthy volunteers but was nearly absent in the patients. The other was a 40 kDa protein with pI 5.2 that was detected in the patients but nearly absent in the healthy volunteers. Analysis of the N-terminal amino acid sequence of the 40 kDa protein revealed that it was a truncated actin with an N-terminus of Met-44. The presence of the truncated actin in the neutrophils of patients was confirmed by Western blot analysis using an antibody to the C-terminus of actin. The 53 kDa protein could not be identified because its N-terminus was blocked. The presence of the truncated actin in the neutrophils of the patients may be important in understanding the pathology of Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823655     DOI: 10.1248/bpb.23.519

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis.

Authors:  Keita Fujimori; Keiko Oh-i; Masaru Takeuchi; Naoyuki Yamakawa; Takaaki Hattori; Takeshi Kezuka; Hiroshi Keino; Jun Suzuki; Hiroshi Goto; Jun-ichi Sakai; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-10       Impact factor: 3.117

2.  Peripheral blood mononuclear cell proteome profile in Behçet's syndrome.

Authors:  Asli Kirectepe Aydin; Yeşim Özgüler; Didar Uçar; Murat Kasap; Gürler Akpınar; Emire Seyahi; Eda Tahir Turanli
Journal:  Rheumatol Int       Date:  2019-08-14       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.